PD Dr. Nathalie Britzen-Laurent



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

p21 Prevents the Exhaustion of CD4+ T Cells Within the Antitumor Immune Response Against Colorectal Cancer (2024) Thoma OM, Naschberger E, Kubánková M, Larafa I, Kramer V, Menchicchi B, Merkel S, et al. Journal article Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer (2023) Zhang J, Zhang S, Dörflein I, Ren X, Pfeffer S, Britzen-Laurent N, Grützmann R, et al. Journal article Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases (2023) Britzen-Laurent N, Weidinger C, Stürzl M Journal article, Review article Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD (2023) Naschberger E, Flierl C, Huang J, Erkert L, Gámez Belmonte MdlR, Gonzalez Acera M, Bober M, et al. Journal article N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy (2023) Krug J, Rodrian G, Petter K, Yang H, Khoziainova S, Guo W, Benard A, et al. Journal article Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator (2023) He H, Zhang S, Yang H, Xu P, Kutschick I, Pfeffer S, Britzen-Laurent N, et al. Journal article CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer (2022) Zeng S, Lan B, Ren X, Zhang S, Schreyer D, Eckstein M, Yang H, et al. Journal article An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer (2022) Yun D, Yang Z, Zhang S, Yang H, Liu D, Grützmann R, Pilarsky C, Britzen-Laurent N Journal article Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer (2022) Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, Xing Y, et al. Journal article CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer (2022) Lan B, Zeng S, Zhang S, Ren X, Xing Y, Kutschick I, Pfeffer S, et al. Journal article
1 2 3 4